In the last decade, more than a dozen types of cancer have risen among people under 50. Scientists don’t have all of the ...
A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...
A drug that costs 5p per tablet and is already widely used to treat malaria may also cut the chances of breast cancer ...
Researchers from Queen Mary University of London's School of Biological and Behavioral Sciences, using the simple fission ...
Tiny, three-dimensional organoid models are reshaping cancer research by recreating the intricate architecture and diversity ...
Hypoxia, or low oxygen in the body, is common in solid tumors. Now, researchers have identified that an RNA molecule, EUDAL, ...
SurvivorNet on MSN
A True Game-Changer in Prostate Cancer: A Simple Genomic Test Can Tell Us Who Needs Hormone Therapy And Who Doesn’t
How do we know which patients truly need this difficult treatment and which patients can safely skip it? The answer has arrived, delivered at the American Society for Radiation Oncology (ASTRO) 2025 ...
You're five times more likely to contract bowel cancer if two very particular factors are present, according to a new ...
News-Medical.Net on MSN
Patient-derived organoids advance cancer therapy and vaccines
Tiny, three-dimensional organoid models are reshaping cancer research by recreating the intricate architecture and diversity of human tumors.
Autophagy, a fundamental cellular process, involves the degradation and recycling of a cell's own components. This intricate ...
News-Medical.Net on MSN
New TOR inhibitor rapalink-1 prolongs chronological lifespan in fission yeast
Researchers from Queen Mary University of London's School of Biological and Behavioural Sciences, using the simple fission yeast as a model, have shown that new TOR inhibitor rapalink-1 prolongs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results